Thebaine O-demethylation to oripavine: Genetic differences between two rat strains

References

• Al-Dabbagh S. G., Idle J. R., Smith R. L. Animal modelling of human polymorphic oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains. Journal of Pharmacy and Pharmacology 1981; 33: 161–164
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Seddon C. E., Davies D. S. Bufuralol 1′-hydroxylase activity of the rat—strain differences and the effects of inhibitors. Biochemical Pharmacology 1986; 35: 2961–2965
   PubMed Web of Science ®Google Scholar
• Brochmann-Hanssen E. A second pathway for the terminal steps in the biosynthesis of morphine. Planta Medica 1984; 51: 343–345
   Google Scholar
• Brochmann-Hanssen E. Biosynthesis of morphinan alkaloids. The Chemistry and Biology of Isoquinoline Alkaloids, J. D. Phillipson, M. F. Roberts, M. H. Zenk. Springer-Verlag, Berlin. Heidelberg, New York, Tokyo 1985; 229–239
   Google Scholar
• Cardinale G. J., Donnerer J., Finck A. D., Kantrowitz J. D., Oka K., Spector S. Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sciences 1987; 40: 301–306
   PubMed Web of Science ®Google Scholar
• Chen Z. R., Somogyi A. A., Reynolds G., Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. British Journal of Clinical Pharmacology 1991; 31: 381–390
   PubMed Web of Science ®Google Scholar
• Chen Z. R., Somogyi A. A., Bochner F. Polymorphic O-demethylation of codeine. Lancet 1988; ii: 914–915
   Google Scholar
• Dayer P., Desmeules J., Leemann T., Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalysing debrisoquine 4-hydroxylation (cytochrome P-450 db1/bufI). Biochemical and Biophysical Research Communications 1988; 152: 411–416
   PubMed Web of Science ®Google Scholar
• Donnerer J., Cardinale G., Coffey J., Lissek C. A., Jardine I., Spector S. Chemical characterization and regulation of endogenous morphine and codeine in the rat. Journal of Pharmacology and Experimental Therapeutics 1987; 242: 583–587
   PubMed Web of Science ®Google Scholar
• Donnerer J., Oka K., Brossi A., Rice K. C., Spector S. Presence and formation of codeine and morphine in the rat. Proceedings of the National Academy of Sciences 1986; 83: 4566–4567
   PubMed Web of Science ®Google Scholar
• Eichelbaum M., Gross A. S. The genetic polymorphism of debrisoquine/sparteine metabolism—clinical aspects. Pharmacology and Therapeutics 1990; 46: 377–394
   PubMed Web of Science ®Google Scholar
• Goldstein A., Barrett R. W., James I. F., Lowney L. I., Weitz C. J., Knipmeyer L. L., Rapoport H. Morphine and other opiates from beef brain and adrenal. Proceedings of the National Academy of Sciences 1985; 82: 5203–5207
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in human deficient debrisoquine metabolism. Nature 1988; 331: 442–446
   PubMed Web of Science ®Google Scholar
• Jaffe J. H., Martin W. R. Opioid analgesics and antagonists. The Pharmacological Basis of Therapeutics, A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor. Pergamon Press, New York 1990; 498
   Google Scholar
• Kahn G. C., Rubenfield M., Davies D. S., Murray S., Boobis A. R. Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat. Drug Metabolism and Disposition 1985; 13: 510–516
   PubMedGoogle Scholar
• Kobayashi S., Murray S., Watson D., Sesardic D., Davies D. S., Boobis A. R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology 1989; 38: 2795–2799
   PubMed Web of Science ®Google Scholar
• Kodaira H., Spector S. Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proceedings of the National Academy of Sciences 1988; 85: 1267–1271
   PubMed Web of Science ®Google Scholar
• Kodaira H., Lisek C. A., Jardine I., Arimura A., Spector S. Identification of the convulsant opiate thebaine in mammalian brain. Proceedings of the National Academy of Sciences 1989; 86: 716–719
   PubMed Web of Science ®Google Scholar
• Kroemer H. K., Mikus G., Kronbach T., Meyer U. A., Eichelbaum M. In vitro characterization of the human cytochrome P-450 involved in the polymorphic oxidation of propafenone. Clinical Pharmacology and Therapeutics 1989; 45: 28–33
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Matsunaga E., Zanger U. M., Hardwick J. P., Gelboin H. V., Meyer U. A., Gonzalez F. J. The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 1989; 28: 7394–7355
   Google Scholar
• Meier P. J., Müller H. K., Dick B., Meyer U. A. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 1983; 85: 682–692
   PubMed Web of Science ®Google Scholar
• Mikus G., Somogyi A. A., Bochner F., Eichelbaum M. Codeine O-demethylation: rat strain differences and the effects of inhibitors. Biochemical Pharmacology 1991; 41: 757–762
   PubMed Web of Science ®Google Scholar
• Misra A. L., Pontani R. B., Mule S. J. Pharmacokinetics and metabolism of [3H]thebaine. Xenobiotica 1974; 4: 17–32
   PubMed Web of Science ®Google Scholar
• Nichols A. I., Peck C. C. LSNLR: A general weighted least squares nonlinear regression program. USUHS version 1.0. Division of Clinical Pharmacology and Medicine, Uniformed Services University for the Health Sciences. 1981, Technical Report No. 5.0
   Google Scholar
• Oguri K., Hanioka N., Yoshimura H. Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guine pigs and rabbits. Xenobiotica 1990; 20: 683–688
   PubMed Web of Science ®Google Scholar
• Oka K., Kantrowitz J. D., Spector S. Isolation of morphine from toad skin. Proceedings of the National Academy of Sciences 1985; 82: 1852–1854
   PubMed Web of Science ®Google Scholar
• Stadler R., Zenk M. H. A revision of the generally accepted pathway for the biosynthesis of the benzyltetrahydroisoquinoline alkaloid reticuline. Liebigs Annalen der Chemie 1990; 555–562
   Google Scholar
• Todd R. D., Muldoon S. M., Watson R. L. Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography 1982; 232: 101–110
   PubMed Web of Science ®Google Scholar
• Weitz C. J., Lowney L. I., Faull K. F., Feistner G., Goldstein A. Morphine and codeine from mammalian brain. Proceedings of the National Academy of Sciences 1986; 83: 9784–9788
   PubMed Web of Science ®Google Scholar
• Yeh S. Y. Analgesic activity and toxicity of oripavine and phi-dihydrothebaine in the mouse and rat. Archives of International Pharmacodynamics 1981; 254: 223–240
   PubMedGoogle Scholar
• Yue Q. Y., Svensson J.-O., Alm C., Sjöqvist F., Säwe J. Codeine O-demethylation cosegregates with polymorphic debrisoquine hydroxylation. British Journal of Clinical Pharmacology 1989; 28: 639–645
   PubMed Web of Science ®Google Scholar
• Zysset T., Zeugin T., Küpfer A. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat: an animal model of the debrisoquine-type polymorphic oxidation in man. Biochemical Pharmacology 1988; 37: 3155–3160
   PubMed Web of Science ®Google Scholar